CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Line of Credit Facility, Increase (Decrease), Net
CHELSEA THERAPEUTICS INTERNATIONAL, LTD. reported Line of Credit Facility, Increase (Decrease), Net of $0 for the 141-month period ending 2013-12-31, per its 10-K filed 2014-03-11.
Discontinued › Notes
us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet · last filed 2014-03-11
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. line of credit facility, increase (decrease), net for the quarter ending 2010-12-31 was $0.00.
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. line of credit facility, increase (decrease), net for the quarter ending 2010-09-30 was $0.00.
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. line of credit facility, increase (decrease), net for fiscal 2013 was $0.00.
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. line of credit facility, increase (decrease), net for fiscal 2012 was $0.00.
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. line of credit facility, increase (decrease), net for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. line of credit facility, increase (decrease), net for fiscal 2010 was $11.47M.
| Period end | Line of Credit Facility, Increase (Decrease), Net 3 month | Line of Credit Facility, Increase (Decrease), Net 6 month | Line of Credit Facility, Increase (Decrease), Net 9 month | Line of Credit Facility, Increase (Decrease), Net 12 month | Line of Credit Facility, Increase (Decrease), Net 129 month | Line of Credit Facility, Increase (Decrease), Net 141 month |
|---|---|---|---|---|---|---|
| 2013-12-31 | $0.00 10-K · filed 2014-03-11 | $0.00 10-K · filed 2014-03-11 | ||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-11 | $0.00 10-K · filed 2013-03-07 | ||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-11 | |||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $0.00 derived: sum of 2 quarters · filed 2013-03-07 | $11.47M 10-K · filed 2013-03-07 | |||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $11.47M 10-Q · filed 2011-11-02 | ||||
| 2010-06-30 | $11.47M 10-Q · filed 2011-07-27 | |||||
| 2009-12-31 | -$4.19M 10-K · filed 2012-03-07 |